Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 8;25(16):3613.
doi: 10.3390/molecules25163613.

The Cyclic Nitronate Route to Pharmaceutical Molecules: Synthesis of GSK's Potent PDE4 Inhibitor as a Case Study

Affiliations

The Cyclic Nitronate Route to Pharmaceutical Molecules: Synthesis of GSK's Potent PDE4 Inhibitor as a Case Study

Evgeny V Pospelov et al. Molecules. .

Abstract

An efficient asymmetric synthesis of GlaxoSmithKline's potent PDE4 inhibitor was accomplished in eight steps from a catechol-derived nitroalkene. The key intermediate (3-acyloxymethyl-substituted 1,2-oxazine) was prepared in a straightforward manner by tandem acylation/(3,3)-sigmatropic rearrangement of the corresponding 1,2-oxazine-N-oxide. The latter was assembled by a (4 + 2)-cycloaddition between the suitably substituted nitroalkene and vinyl ether. Facile acetal epimerization at the C-6 position in 1,2-oxazine ring was observed in the course of reduction with NaBH3CN in AcOH. Density functional theory (DFT) calculations suggest that the epimerization may proceed through an unusual tricyclic oxazolo(1,2)oxazinium cation formed via double anchimeric assistance from a distant acyloxy group and the nitrogen atom of the 1,2-oxazine ring.

Keywords: C–H functionalization; PDE4 inhibitors; anchimeric assistance; epimerization; pyrrolidines; total synthesis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Scheme 1
Scheme 1
Approaches towards modification of cyclic nitronates. (a) Synthesis of cyclic nitronates from nitroalkenes; (b) 1,3-Dipolar addition with cyclic nitronates and its application in total synthesis; (c) C-H functionalization of cyclic nitronates via N-siloxyenamines (route 1); (d) C-H functionalization of cyclic nitronates via [3,3]-rearrangement of N-acyloxyenamines (route 2).
Scheme 2
Scheme 2
Previous asymmetric synthesis of (−)-CMPO.
Scheme 3
Scheme 3
Problems associated with C-6 epimerization in the LA-assisted functionalization of cyclic nitronate 10. (a) Functionalization of cyclic nitronate 10; (b) Mechanism of epimerization at C-6; (c) Hydride reduction of 4,6-cis-1,2-oxazines.
Scheme 4
Scheme 4
Tandem acylation/(3,3)-rearrangement of nitronate 10.
Scheme 5
Scheme 5
Cyanoborohydride reduction of 3-hydroxymethyl 1,2-oxazine 13 and its pivalate 17.
Scheme 6
Scheme 6
Conversion of 1,2-oxazines 18 and 18′ into target PDE4 inhibitor (−)-CMPO.
Scheme 7
Scheme 7
Plausible mechanism of the epimerization at the C-6 position in 1,2-oxazine 18. Ar − 4-methoxy-3-cyclopentyloxyphenyl, G*—trans-2-phenylcyclohexyl. DFT calculations: MN15/Def2TZVP (AcOH, smd), LA was not included in the calculations.
Figure 1
Figure 1
Numeration of atoms in products 1720.

References

    1. Denmark S.E., Thorarensen A. Tandem [4 + 2]/[3 + 2] Cycloadditions of Nitroalkenes. Chem. Rev. 1996;96:137–166. doi: 10.1021/cr940277f. - DOI - PubMed
    1. Tabolin A.A., Sukhorukov A.Y., Ioffe S.L., Dilman A.D. Recent Advances in the Synthesis and Chemistry of Nitronates. Synthesis. 2017;49:3255–3268. doi: 10.1055/s-0036-1589063. - DOI
    1. Mukaijo Y., Yokoyama S., Nishiwaki N. Comparison of Substituting Ability of Nitronate versus Enolate for Direct Substitution of a Nitro Group. Molecules. 2020;25:2048. doi: 10.3390/molecules25092048. - DOI - PMC - PubMed
    1. de Carvalho L.L., Burrow R.A., Pereira V.L.P. Diastereoselective synthesis of nitroso acetals from (S,E)-γ-aminated nitroalkenes via multicomponent [4 + 2]/[3 + 2] cycloadditions promoted by LiCl or LiClO4. Beilstein J. Org. Chem. 2013;9:838–845. doi: 10.3762/bjoc.9.96. - DOI - PMC - PubMed
    1. Kano T., Yamamoto A., Song S., Maruoka K. Catalytic asymmetric syntheses of isoxazoline-N-oxides under phase-transfer conditions. Chem. Commun. 2011;47:4358–4360. doi: 10.1039/c0cc05786j. - DOI - PubMed

MeSH terms